• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩张型心肌病的复杂多样的遗传结构。

The Complex and Diverse Genetic Architecture of Dilated Cardiomyopathy.

机构信息

Divisions of Cardiovascular Medicine (R.E.H.), The Ohio State University Wexner Medical Center, Columbus.

Human Genetics (R.E.H., J.C., E.J., D.D.K.), The Ohio State University Wexner Medical Center, Columbus.

出版信息

Circ Res. 2021 May 14;128(10):1514-1532. doi: 10.1161/CIRCRESAHA.121.318157. Epub 2021 May 13.

DOI:10.1161/CIRCRESAHA.121.318157
PMID:33983834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8158434/
Abstract

Our insight into the diverse and complex nature of dilated cardiomyopathy (DCM) genetic architecture continues to evolve rapidly. The foundations of DCM genetics rest on marked locus and allelic heterogeneity. While DCM exhibits a Mendelian, monogenic architecture in some families, preliminary data from our studies and others suggests that at least 20% to 30% of DCM may have an oligogenic basis, meaning that multiple rare variants from different, unlinked loci, determine the DCM phenotype. It is also likely that low-frequency and common genetic variation contribute to DCM complexity, but neither has been examined within a rare variant context. Other types of genetic variation are also likely relevant for DCM, along with gene-by-environment interaction, now established for alcohol- and chemotherapy-related DCM. Collectively, this suggests that the genetic architecture of DCM is broader in scope and more complex than previously understood. All of this elevates the impact of DCM genetics research, as greater insight into the causes of DCM can lead to interventions to mitigate or even prevent it and thus avoid the morbid and mortal scourge of human heart failure.

摘要

我们对扩张型心肌病 (DCM) 遗传结构的多样性和复杂性的认识正在迅速发展。DCM 遗传学的基础在于明显的位置和等位基因异质性。虽然 DCM 在一些家族中表现出孟德尔单基因结构,但我们的研究和其他研究的初步数据表明,至少 20% 至 30% 的 DCM 可能具有寡基因基础,这意味着来自不同非连锁位置的多个罕见变异决定了 DCM 表型。低频和常见的遗传变异也可能与 DCM 的复杂性有关,但在罕见变异的背景下都没有进行过研究。其他类型的遗传变异也可能与 DCM 有关,基因-环境相互作用也已被确定与酒精和化疗相关的 DCM 有关。总的来说,这表明 DCM 的遗传结构比以前理解的范围更广,也更复杂。所有这些都提高了 DCM 遗传学研究的重要性,因为对 DCM 病因的更深入了解可以导致干预措施来减轻甚至预防它,从而避免人类心力衰竭的病态和致命的困扰。

相似文献

1
The Complex and Diverse Genetic Architecture of Dilated Cardiomyopathy.扩张型心肌病的复杂多样的遗传结构。
Circ Res. 2021 May 14;128(10):1514-1532. doi: 10.1161/CIRCRESAHA.121.318157. Epub 2021 May 13.
2
Considering complexity in the genetic evaluation of dilated cardiomyopathy.考虑扩张型心肌病遗传评估中的复杂性。
Heart. 2021 Jan;107(2):106-112. doi: 10.1136/heartjnl-2020-316658. Epub 2020 Oct 27.
3
Dilated cardiomyopathy: the complexity of a diverse genetic architecture.扩张型心肌病:多样化遗传结构的复杂性。
Nat Rev Cardiol. 2013 Sep;10(9):531-47. doi: 10.1038/nrcardio.2013.105. Epub 2013 Jul 30.
4
Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy.扩张型心肌病患者中罕见肌节基因变异的预后不良。
Clin Transl Sci. 2013 Dec;6(6):424-8. doi: 10.1111/cts.12116. Epub 2013 Oct 3.
5
Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals.扩张型心肌病的临床和遗传问题:遗传学专业人员的综述。
Genet Med. 2010 Nov;12(11):655-67. doi: 10.1097/GIM.0b013e3181f2481f.
6
Implications of Genetic Testing in Dilated Cardiomyopathy.扩张型心肌病的基因检测意义。
Circ Genom Precis Med. 2020 Oct;13(5):476-487. doi: 10.1161/CIRCGEN.120.003031. Epub 2020 Sep 3.
7
Genetics and genomics of dilated cardiomyopathy and systolic heart failure.扩张型心肌病和收缩性心力衰竭的遗传学与基因组学
Genome Med. 2017 Feb 22;9(1):20. doi: 10.1186/s13073-017-0410-8.
8
Pathogenic Variants Associated With Dilated Cardiomyopathy Predict Outcome in Pediatric Myocarditis.与扩张型心肌病相关的致病性变异可预测小儿心肌炎的结局。
Circ Genom Precis Med. 2021 Aug;14(4):e003250. doi: 10.1161/CIRCGEN.120.003250. Epub 2021 Jul 2.
9
Second Hits in Dilated Cardiomyopathy.扩张型心肌病中的二次打击。
Curr Cardiol Rep. 2020 Jan 24;22(2):8. doi: 10.1007/s11886-020-1260-3.
10
Exome sequencing and genome-wide linkage analysis in 17 families illustrate the complex contribution of TTN truncating variants to dilated cardiomyopathy.对17个家庭进行的外显子组测序和全基因组连锁分析表明,TTN截短变异对扩张型心肌病的影响较为复杂。
Circ Cardiovasc Genet. 2013 Apr;6(2):144-53. doi: 10.1161/CIRCGENETICS.111.000062. Epub 2013 Feb 15.

引用本文的文献

1
The Emergency Resection of a Mobile Left Ventricular Thrombus in Dilated Cardiomyopathy: A Case of Multiorgan Embolism and Postoperative Ventricular Tachycardia.扩张型心肌病中可移动左心室血栓的急诊切除:多器官栓塞及术后室性心动过速一例
Cureus. 2025 Aug 10;17(8):e89756. doi: 10.7759/cureus.89756. eCollection 2025 Aug.
2
Implementing Precision Medicine for Dilated Cardiomyopathy: Insights From the DCM Consortium.实施扩张型心肌病的精准医学:来自扩张型心肌病联盟的见解
Circ Genom Precis Med. 2025 Aug;18(4):e005078. doi: 10.1161/CIRCGEN.125.005078. Epub 2025 Jun 18.
3
Identification of a rare variant in TNNT3 responsible for familial dilated cardiomyopathy through whole-exome sequencing and in silico analysis.

本文引用的文献

1
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).临床外显子组和基因组测序中次要发现报告的建议,2021年更新:美国医学遗传学与基因组学学会(ACMG)政策声明
Genet Med. 2021 Aug;23(8):1391-1398. doi: 10.1038/s41436-021-01171-4. Epub 2021 May 20.
2
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会(ACMG)关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.0清单:一项政策声明
Genet Med. 2021 Aug;23(8):1381-1390. doi: 10.1038/s41436-021-01172-3. Epub 2021 May 20.
3
通过全外显子测序和计算机分析鉴定出TNNT3基因中一个导致家族性扩张型心肌病的罕见变异。
Eur J Med Res. 2025 May 28;30(1):424. doi: 10.1186/s40001-025-02692-3.
4
Common genetic modifiers influence cardiomyopathy susceptibility among the carriers of rare pathogenic variants.常见的基因修饰因子会影响罕见致病变异携带者患心肌病的易感性。
HGG Adv. 2025 May 22:100460. doi: 10.1016/j.xhgg.2025.100460.
5
Environmental Risk Factors Are Associated With the Natural History of Familial Dilated Cardiomyopathy.环境风险因素与家族性扩张型心肌病的自然病史相关。
J Am Heart Assoc. 2025 May 6;14(9):e037311. doi: 10.1161/JAHA.124.037311. Epub 2025 May 2.
6
Screening single nucleotide changes to tropomyosin to identify novel cardiomyopathy mutants.筛选原肌球蛋白的单核苷酸变化以鉴定新型心肌病突变体。
J Mol Cell Cardiol. 2025 Jun;203:82-90. doi: 10.1016/j.yjmcc.2025.04.009. Epub 2025 Apr 21.
7
The Prognostic Significance of the DBIL/HDLC Ratio in Patients With Dilated Cardiomyopathy.直接胆红素与高密度脂蛋白胆固醇比值在扩张型心肌病患者中的预后意义
Cardiovasc Ther. 2025 Feb 15;2025:8835736. doi: 10.1155/cdr/8835736. eCollection 2025.
8
A New Perspective on the Role of Alterations in Mitochondrial Proteins Involved in ATP Synthesis and Mobilization in Cardiomyopathies.关于参与心肌病中ATP合成与转运的线粒体蛋白改变作用的新视角
Int J Mol Sci. 2025 Mar 19;26(6):2768. doi: 10.3390/ijms26062768.
9
Dilated cardiomyopathy signature metabolic marker screening: Machine learning and multi-omics analysis.扩张型心肌病特征性代谢标志物筛查:机器学习与多组学分析
Heliyon. 2025 Jan 13;11(3):e41927. doi: 10.1016/j.heliyon.2025.e41927. eCollection 2025 Feb 15.
10
Regulatory mechanisms of mA methylation in dilated cardiomyopathy.扩张型心肌病中 mA 甲基化的调控机制
Am J Transl Res. 2025 Jan 15;17(1):47-59. doi: 10.62347/AOSK8903. eCollection 2025.
Evidence-Based Assessment of Genes in Dilated Cardiomyopathy.基于证据的扩张型心肌病相关基因评估。
Circulation. 2021 Jul 6;144(1):7-19. doi: 10.1161/CIRCULATIONAHA.120.053033. Epub 2021 May 5.
4
Promise and Peril of Population Genomics for the Development of Genome-First Approaches in Mendelian Cardiovascular Disease.人口基因组学在孟德尔心血管疾病中发展基于基因组优先方法的前景与挑战。
Circ Genom Precis Med. 2021 Feb;14(1):e002964. doi: 10.1161/CIRCGEN.120.002964. Epub 2021 Feb 1.
5
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect.共同的遗传途径导致肥厚型和扩张型心肌病的风险增加,但其作用方向相反。
Nat Genet. 2021 Feb;53(2):128-134. doi: 10.1038/s41588-020-00762-2. Epub 2021 Jan 25.
6
Amino Acid-Level Signal-to-Noise Analysis Aids in Pathogenicity Prediction of Incidentally Identified -Encoded Titin Truncating Variants.氨基酸水平信号噪声分析有助于预测偶然发现的编码肌联蛋白截断变异体的致病性。
Circ Genom Precis Med. 2021 Feb;14(1):e003131. doi: 10.1161/CIRCGEN.120.003131. Epub 2020 Nov 23.
7
Considering complexity in the genetic evaluation of dilated cardiomyopathy.考虑扩张型心肌病遗传评估中的复杂性。
Heart. 2021 Jan;107(2):106-112. doi: 10.1136/heartjnl-2020-316658. Epub 2020 Oct 27.
8
Impact of variant reclassification in the clinical setting of cardiovascular genetics.心血管遗传学临床环境中变异重新分类的影响。
J Genet Couns. 2021 Apr;30(2):503-512. doi: 10.1002/jgc4.1336. Epub 2020 Oct 7.
9
Genotype-phenotype correlations in recessive titinopathies.隐性肌联蛋白病的基因型-表型相关性
Genet Med. 2020 Dec;22(12):2029-2040. doi: 10.1038/s41436-020-0914-2. Epub 2020 Aug 11.
10
The mutational constraint spectrum quantified from variation in 141,456 humans.从 141456 名人类个体的变异中量化的突变约束谱。
Nature. 2020 May;581(7809):434-443. doi: 10.1038/s41586-020-2308-7. Epub 2020 May 27.